Clinical Trial: Rifaximin Use in Severe Alcoholic Hepatitis

Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional

Official Title: Effect of Gut Decontamination Using Rifaximin in the Patients With Severe Alcoholic Hepatitis

Brief Summary: This study aimed to investigate the effect of decontamination by rifaximin in severe alcoholic hepatitis patients. Patients who take corticosteroid or pentoxifylline will be randomly allocated to rifaximin group or control group.

Detailed Summary:
Sponsor: Saint Vincent's Hospital, Korea

Current Primary Outcome: Mortality [ Time Frame: 6-month ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Saint Vincent's Hospital, Korea

Dates:
Date Received: June 24, 2015
Date Started: July 2015
Date Completion:
Last Updated: June 25, 2015
Last Verified: June 2015